Abstract
This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
| Original language | English |
|---|---|
| Pages (from-to) | 1073-1089 |
| Number of pages | 17 |
| Journal | European heart journal cardiovascular Imaging |
| Volume | 18 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2017 |
Bibliographical note
Copyright © 2017 European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.Keywords
- Cardiac Imaging Techniques/standards
- Cardiology/standards
- Cardiomyopathies/diagnostic imaging
- Europe
- Female
- Humans
- Magnetic Resonance Imaging/standards
- Male
- Multimodal Imaging/standards
- Myocardial Perfusion Imaging/standards
- Nuclear Medicine/standards
- Positron Emission Tomography Computed Tomography/standards
- Practice Guidelines as Topic
- Radionuclide Imaging/standards
- Sarcoidosis/diagnostic imaging
- Societies, Medical
- United States
Fingerprint
Dive into the research topics of 'A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver